We are monitoring the impact of COVID-19 on Europe HPV Testing And Pap Test Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3623
Share on
Share on

Europe HPV Testing and Pap Test Market Research Report – Segmented By Application, Test Type, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3623
Pages: 145

Europe HPV Testing and Pap Test Market Size (2021 to 2026)

The HPV Testing and Pap Test Market size in Europe is estimated to be worth USD 1.38 billion by 2026 and USD 1.03 billion in 2021, growing at a CAGR of 6.10% during the forecast period. It captures 25% of the global market.

The rising number of patients diagnosed with cervical cancer, the growing elderly population, and greater awareness about cervical cancer screening programs contribute to the European HPV testing and pap test market growth. Doctors use Pap testing to confirm cervical cancer in women or to investigate alterations in cells that might lead to cervical cancer in the future. Because of the disease's high incidence and death rate, there is a great need for novel and reliable early detection and therapy screening. Furthermore, market development is expected to be aided by innovative testing methods and services that would increase screening rates. Therefore, one of the key factors expected to drive Europe's HPV testing and Pap test market over the forecast period is rising demand for technologically advanced diagnostic procedures for screening cervical and vaginal cancers.

Because of the HPV test's excellent sensitivity, it can be used to extend screening intervals and enhance screening coverage in high-risk populations. Alternative approaches such as HPV testing have emerged due to the failure of cytology-based screening programs in this region. The rising need for improved cancer diagnostics, as well as recent advances in cancer diagnosis and therapy, novel specific antigen discovery, and insights linked to cancer's genetic foundation, have all contributed to the market's rise. The growing elderly population will also add gasoline to this industry, as they will increase demand for additional cancer assays and tests, resulting in the future market growth in Europe. For women aged 25 and older, one HPV test has just been approved for use as primary cervical cancer screening, followed by a Pap test for women with specific findings. Many additional tests are also being developed to enhance the assessment of HPV-positive women. As a result of the rising demand for Pap, HPV, and other cancer screening tests, the market has grown.

The European HPV Testing and Pap Test market is projected to be restrained by regulatory clearances for screening techniques, an uncertain reimbursement environment over the forecast period. The authorized tests on the market are for detecting cervical cancer in women. They are ineffective in males for detecting HPV-related malignancies or genital warts. Because of the restricted product availability, the market's growth has been constrained to a single gender, resulting in modest development during the forecast period.

Changes in regulatory guidelines for cervical cancer screening and the HPV vaccine are key challenges to the European HPV testing and Pap test market growth.

This research report on the Europe HPV Testing and Pap Test Market has been segmented and sub-segmented into the following categories:

By Test Type:

  • HPV Testing
  • Follow-up HPV Testing
  • HPV Primary Testing
  • Co-Testing
  • PAP Test

By Application:

  • Vaginal Cancer Screening
  • Cervical Cancer Screening

By End-users:

  • Laboratories
  • Hospitals
  • Physicians
  • Offices
  • Clinics

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

Regionally, Europe is the second-largest market in terms of market share in the global market. The UK is the leading market in this region. Government leaders, members of parliament, and activists should be aware that the much larger scale of this public health crisis in the EU's east requires special attention. The high levels of awareness of the condition and the testing methods and related advantages among the people of these areas were major drivers in the market's rise in these regions. Cervical cancer, often known as uterine cancer, is becoming a major public health concern in several European nations. Cervical cancer is particularly prevalent in the new member nations. Romania and Lithuania now have the highest yearly death rates, while Finland has the lowest.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the European HPV Testing and PAP Test Market profiled in this report are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc., and Arbor Vita Corporation.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Type                                                                              

                                5.1.1 Introduction                                                           

                                5.1.2 HPV Testing                                                            

                                5.1.3 Follow-Up HPV Testing                                                      

                                5.1.4 Co-Testing                                                               

                                5.1.5 Primary HPV Testing                                                           

                                5.1.6 PAP Test                                                  

                                5.1.7  Y-o-Y Growth Analysis, By Type                                                    

                                5.1.8  Market Attractiveness Analysis, By Type                                                  

                                5.1.9  Market Share Analysis, By Type                                                    

                5.2 Application                                                                 

                                5.2.1 Introduction                                                           

                                5.2.2 Cervical Cancer Screening                                                 

                                5.2.3 Vaginal Cancer Screening                                                  

                                5.2.4 Y-o-Y Growth Analysis, By Application                                                         

                                5.2.5 Market Attractiveness Analysis, By Application                                                       

                                5.2.6 Market Share Analysis, By Application                                                        

                5.3 End User                                                                      

                                5.3.1 Introduction                                                           

                                5.3.2 Laboratories                                                           

                                5.3.3 Hospitals                                                  

                                5.3.4 Physicians’ Offices and Clinics                                                         

                                5.3.5 Y-o-Y Growth Analysis, By End User                                                             

                                5.3.6  Market Attractiveness Analysis, By End User                                                          

                                5.3.7  Market Share Analysis, By End User                                                            

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Type                                 

                                                6.1.3.3 By Application                                    

                                                6.1.3.4 By End User                                        

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Type                                 

                                                6.1.4.3 By Application                                    

                                                6.1.4.4 By End User                                        

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Type                                 

                                                6.1.5.3 By Application                                    

                                                6.1.5.4 By End User                                        

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Qiagen N.V.                                                                

                8.3 Roche Diagnostics                                                                    

                8.4 Hologic, Inc.                                                                

                8.5 Becton, Dickinson and Company                                                                       

                8.6 Quest Diagnostics                                                                    

                8.7 Onco Health Corporation                                                                      

                8.8 Seegene, Inc.                                                                            

                8.9 Femasys Inc.                                                                              

                8.10 Arbor Vita Corporation                                                                        

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Market Outlook and Investment Opportunities                                                                                         

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of application, test type and end user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the europe market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe HPV testing and Pap Test Market, By Type, From 2021 to 2026 (USD Billion)
  2. Europe HPV Testing Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Follow-up HPV Testing Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Co-testing Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe HPV Primary testing Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Pap Test Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe HPV testing and Pap Test Market, By Application, From 2021 to 2026 (USD Billion)
  8. Europe Pap Test Market, By Region, From 2021 to 2026 (USD Billion)
  9. Europe Cervical Cancer Screening Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Vaginal Cancer Screening Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe HPV testing and Pap Test Market, By End User, From 2021 to 2026 (USD Billion)
  12. Europe Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe Physician’s Offices & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  15. U.K. HPV testing and Pap Test Market, By Type, From 2021 to 2026 (USD Billion)
  16. U.K. HPV testing and Pap Test Market, By Application, From 2021 to 2026 (USD Billion)
  17. U.K. HPV testing and Pap Test Market, By End User, From 2021 to 2026 (USD Billion)
  18. Germany HPV testing and Pap Test Market, By Type, From 2021 to 2026 (USD Billion)
  19. Germany HPV testing and Pap Test Market, By Application, From 2021 to 2026 (USD Billion)
  20. Germany HPV testing and Pap Test Market, By End User, From 2021 to 2026 (USD Billion)
  21. France HPV testing and Pap Test Market, By Type, From 2021 to 2026 (USD Billion)
  22. France HPV testing and Pap Test Market, By Application, From 2021 to 2026 (USD Billion)
  23. France HPV testing and Pap Test Market, By End User, From 2021 to 2026 (USD Billion)
  24. Italy HPV testing and Pap Test Market, By Type, From 2021 to 2026 (USD Billion)
  25. Italy HPV testing and Pap Test Market, By Application, From 2021 to 2026 (USD Billion)
  26. Italy HPV testing and Pap Test Market, By End User, From 2021 to 2026 (USD Billion)
  27. Spain HPV testing and Pap Test Market, By Type, From 2021 to 2026 (USD Billion)
  28. Spain HPV testing and Pap Test Market, By Application, From 2021 to 2026 (USD Billion)
  29. Spain HPV testing and Pap Test Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample